Arch Therapeutics Inc (ARTH) 0.6200 $ARTH Arch

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Arch Therapeutics Inc (ARTH) 0.6200 $ARTH

Arch Therapeutics Reports AC5 Topical Hemostatic Device Meets Primary and Secondary Endpoints in First Clinical Study
Marketwire Canada - Mon Aug 15, 5:57AM CDT
Clinical Safety and Performance of AC5 Successfully Demonstrated in Dermatology Procedure Performed on 46 Skin Lesion Patients With Bleeding Wounds

Arch Therapeutics Completes Patient Enrollment in Clinical Study of AC5
Marketwire Canada - Mon Jun 06, 6:57AM CDT
Data Expected During Summer 2016 After Completion of 30-Day Follow-Up and Subsequent Statistical Analysis

Arch Therapeutics Announces May 26, 2016 $3.4 Million Private Placement
Marketwired - Fri May 27, 8:00AM CDT
FRAMINGHAM, MA--(Marketwired - May 27, 2016) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company", developer of the AC5 Surgical Hemostatic Device™ (AC5™) for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, is pleased to announce that it has entered into subscription agreements with a group of accredited investors (the "Investors" to purchase approximately $3.4 million of the Company's securities in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Regulation D promulgated thereunder (the "Private Placement".

Arch Therapeutics Announces Issuance of Composition of Matter Patent Covering Self-Assembling Peptidomimetics
Marketwire Canada - Mon May 16, 6:57AM CDT
U.S. Patent Addresses Self-Assembling Peptidomimetics That Form Barrier Structures on Tissue and Inhibit or Prevent the Passage of Bodily Fluids and Contaminants

Arch Therapeutics Receives Notice of Allowance for Composition of Matter and Method of Use Patent Covering Solid Forms of Self-Assembling Peptides
Marketwire Canada - Tue May 10, 6:57AM CDT
U.S. Patent Addresses Controlling the Movement of Bodily Fluids With Meshes That Include Self-Assembling Peptides

Arch Therapeutics Receives Notice of Allowance for Patent Covering Systemic Applications for Self-Assembling Peptides
Marketwired - Tue May 03, 8:19PM CDT
U.S. Patent Addresses Use of the Self-Assembling Peptide Barrier Technology to Treat Disorders Involving Leaky Tight Junctions and Extracellular Matrix

Revenue up 354% in 3D Printing And Royalty Agreement with Fortune 500 Manufacturer - Other Stocks to Watch
ACCESSWIRE - Mon May 02, 7:30AM CDT
MIAMI, FL / ACCESSWIRE / May 2, 2016 / EmergingGrowth.com - Graphene 3D Lab, Inc. (OTCQB: GPHBF) just released its quarterly report for the period ending February 29, 2016 showing an increase in revenue of 354% over their November 30, 2016 quarter.
TERP: 12.17 (+0.25), GS: 165.55 (+2.30), UPL: 0.31 (unch), HPQ: 14.52 (+0.24)

Arch Therapeutics to Present at PIONEERS 2016 by Joseph Gunnar & Co. Thursday, May 5, 2016
Marketwired - Tue Apr 26, 6:57AM CDT
Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company", developer of the AC5 Surgical Hemostatic Device(TM) (AC5(TM)) for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, will present at PIONEERS 2016, hosted by Joseph Gunnar & Co., on Thursday, May 5, 2016 at 4:30 PM EDT.

Arch Therapeutics Announces Notice of Allowance for Method of Use Patent Covering Uses of Self-Assembling Peptides
Marketwired - Mon Apr 11, 6:57AM CDT
Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company", developer of the AC5 Surgical Hemostatic Device(TM) (AC5(TM)) for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, announced today that a notice of allowance from the U.S. Patent Office has been received on a broad method of use patent assigned to the Massachusetts Institute of Technology (MIT) and Versitech Limited, and which is exclusively licensed worldwide to Arch. The broad method claims of the patent cover techniques for preventing the loss or unwanted movement of body fluids, through the application of Arch's present and future potential products in development. These potential products contain peptides that self-assemble into barrier structures on tissue that inhibit or prevent the passage of bodily fluids. Examples of procedures supported by this intellectual property include the use of hemostatic agents to stop bleeding and use of sealants to stop leaks.

Pre-Market Alert - 4 Stocks That You Should Be Watching Today (4/7/2016)
ACCESSWIRE - Thu Apr 07, 8:08AM CDT
NEW YORK, NY / ACCESSWIRE / April 7, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. MSTX, REXX, ARTH and TRTC are on high volume alert. Continue reading to find out why these stocks are getting so much interest today. - If you want reports on the day's hottest stocks (NYSE/Nasdaq/OTC) subscribe to our newsletter at otc-expert.com.
MSTX: 0.42 (+0.03), REXX: 0.62 (+0.05)

Arch Therapeutics Announces Notice of Allowance for Composition-of-Matter Patent Covering Self-Assembling Peptides
Marketwired - Tue Apr 05, 6:57AM CDT
Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company", developer of the AC5 Surgical Hemostatic Device(TM) (AC5(TM)) for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, announced today that a notice of allowance from the U.S. Patent Office has been received on a broad composition-of-matter patent that is assigned to the Massachusetts Institute of Technology (MIT) and Versitech Limited, and which is exclusively licensed worldwide to Arch. The broad composition claims of the patent cover Arch's present and proposed products, which contain peptides that self-assemble into barrier structures on tissue that inhibit or prevent the passage of bodily fluids. Examples of potential products supported by this intellectual property include hemostatic agents to stop bleeding and sealants to stop leaks.

Arch Therapeutics Obtains Favorable Safety Data for AC5 Surgical Hemostatic Device(TM) in Skin Irritation Testing in Humans
Marketwired - Tue Mar 22, 6:57AM CDT
Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company", developer of the AC5 Surgical Hemostatic Device(TM) ("AC5(TM)", reports favorable data from a 21-day repeat exposure skin test to evaluate the irritation potential of AC5 to human skin. This represents the first safety data obtained for AC5 from human testing.

Arch Therapeutics, Inc. (OTCQB: ARTH) Patient Enrollment and Treatment in First Clinical Trial in Western Europe
ACCESSWIRE - Mon Mar 14, 12:04PM CDT
FRAMINGHAM, MA / ACCESSWIRE / March 14, 2016 / Arch Therapeutics, Inc. (OTCQB: ARTH) a life science medical device company focused on developing an approach for the cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care, has recently announced that it has initiated patient enrollment and treatment in its first clinical trial in Western Europe. Terrence W. Norchi, MD, President and CEO of Arch, said, "The start of this trial marks a major milestone for the Company. It is firmly underway with patients being actively screened, enrolled, and treated or scheduled for treatment. Our team has put in tremendous effort to get us to this point and we are pleased with this progress."

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 28

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 161

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 78

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 342

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 86

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 24

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 207

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Mercy Medical Center Nurses Mobilize for Patient Safety Picket

Updated Category News Views 35

Nurses Standing Together for Patient Safety Nurses at Mercy Medical Center are uniting for a cause that affects them profoundly: the safety of their patients and the workplace. With issues surrounding unsafe staffing and deteriorating care conditions, nurses represented by the Massachusetts Nurses Association plan to hold an informational picket. This demonstration is not...

Continue Reading
Massive Merger: Qorvo and Skyworks Unite for Future Innovations

Updated Category News Views 306

Overview of the Strategic Merger In an exciting development in the technology sector, shares of Qorvo, Inc. (NASDAQ: QRVO) and Skyworks Solutions, Inc. (NASDAQ: SWKS) are experiencing a notable surge after announcing their intent to merge. This deal, which values the combined entity at approximately $22 billion, marks a significant step forward in the realm of...

Continue Reading
Oryzon Genomics Announces Corporate Updates for September

Updated Category News Views 178

Oryzon Genomics to Share Updates on Corporate Progress Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a leading clinical-stage biopharmaceutical company dedicated to epigenetic therapies for critical medical needs, is set to present its latest corporate updates at several major international events. These important gatherings scheduled for September will showcase...

Continue Reading
Envision Energy Launches Innovative Energy Storage Solution

Updated Category News Views 363

Introducing the EN 8 Pro: A Revolution in Energy Storage Envision Energy, a leader in sustainable technology, has made a significant breakthrough in energy management with the launch of its EN 8 Pro 8MWh DC Liquid-Cooled Energy Storage System. This innovative setup is set to establish new industry standards in safety, efficiency, and environmental adaptability. Designed...

Continue Reading
Beard Papa's Teams Up for Exciting Zenless Zone Zero Launch

Updated Category News Views 528

Beard Papa's Exciting Flavor Collaboration Begins Beard Papa's, renowned for its delectable cream puffs and irresistible custard fillings, is thrilled to announce a nationwide collaboration with Zenless Zone Zero. This partnership will launch an exciting in-game event that will allow fans to experience the unique flavors inspired by the action-RPG sensation from...

Continue Reading